Trial of Excision Versus Photodynamic Therapy in the Treatment of Bowen's Disease
NCT ID: NCT00472706
Last Updated: 2010-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
65 participants
INTERVENTIONAL
2007-05-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Excision Versus Photodynamic Therapy and Topical 5-fluorouracil in Treatment of Bowen's Disease
NCT03909646
Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease
NCT03320447
Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease
NCT01912976
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
NCT03012009
Photodynamic Therapy of Actinic Keratoses With Alacare®
NCT01571336
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Excision
excision
excision 3 mm margin
2
Photodynamic therapy
Photodynamic therapy
Photodynamic therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
excision
excision 3 mm margin
Photodynamic therapy
Photodynamic therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histological proven Bowen's disease on scalp, face, trunk, arms and legs
* Informed Consent
Exclusion Criteria
* Anogenital or subungual Bowe's disease
* Other skin malignancy in the same area
* Porphyria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasmus Medical Center
OTHER
Catharina Ziekenhuis Eindhoven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Catharina hospital/Erasmus MC
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annette Verzijl, MD
Role: PRINCIPAL_INVESTIGATOR
Catharina hospital/Erasmus MC
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M06-16107
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.